Ali Amirkhosravi

3.2k citations
62 papers · 2.5k indexed · h-index 27

Ali Amirkhosravi

60 papers receiving 2.4k citations

Peers

Ali Amirkhosravi
Comparison fields: 5 of 102
  • Internal Medicine 630
  • Hematology 898
  • Immunology and Allergy 225
  • Oncology 720
  • Immunology 516
Replace Laurence Panicot‐Dubois with:
Laurence Panicot‐Dubois France
Glenn Merrill‐Skoloff United States
Stéphane Loyau France
Vladimir Y. Bogdanov United States
Ewa Sierko Poland
BS Coller United States
J.J. Emeis Netherlands
Jean Marie Stassen Belgium
Sebastian F. Mause Germany
Paula B. Tracy United States
Ali Amirkhosravi relative to Laurence Panicot‐Dubois France Laurence Panicot‐Dubois's profile →
Citations per field
00.5×1.5×
Laurence Panicot‐Dubois · 1×
Citations per year

Countries citing papers authored by Ali Amirkhosravi

Since Specialization
Citations

This map shows the geographic impact of Ali Amirkhosravi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Amirkhosravi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Amirkhosravi more than expected).

Fields of papers citing papers by Ali Amirkhosravi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Amirkhosravi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Amirkhosravi. The network helps show where Ali Amirkhosravi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ali Amirkhosravi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ali Amirkhosravi Line = papers co-authored together Ali Amirkhosravi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20227
2 201629
3 201532
4 2013166
5 20139
6 201332
7 201020
8 20103
9 200696
10 200526
11 200516
12 200572
13 200418
14 200392
15 2003117
16 199967
17 199818
18 1998113
19 199712
20 199613

About Ali Amirkhosravi

Ali Amirkhosravi is a scholar working on Internal Medicine, Hematology and Immunology and Allergy, having authored 62 papers that have together received 2.5k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (30 papers), Blood Coagulation and Thrombosis Mechanisms (19 papers), Venous Thromboembolism Diagnosis and Management (17 papers), Cell Adhesion Molecules Research (15 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Heparin-Induced Thrombocytopenia and Thrombosis (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers) and Blood properties and coagulation (4 papers). The work is most often cited by research in Internal Medicine (630 citations), Hematology (898 citations) and Immunology and Allergy (225 citations). Ali Amirkhosravi has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include John L. Francis, Todd Meyer, J L Francis, Mildred Amaya, Hina Desai, John Biggerstaff, Shaker A. Mousa, John Francis, Florian Länger and M. Amaya. Their work appears in journals such as Blood, The Journal of Immunology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026